Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin

Author: Ho Mitchell  

Publisher: Adis International

ISSN: 1173-8804

Source: BioDrugs, Vol.25, Iss.5, 2011-10, pp. : 275-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract